Vimarsana
Biggest News Aggregation in the World

Page 2 - Peter Aaby News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Peter Aaby. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Peter Aaby Today - Breaking & Trending Today

An Old TB Vaccine Might Help Stave Off Diabetes, Cancer Alzheimer's, and More - Vimarsana News

An Old TB Vaccine Might Help Stave Off Diabetes, Cancer Alzheimer's, and More

The BCG vaccine might help prevent a range of major diseases

Surprising Immune-Boosting Benefits of Tuberculosis Vaccine - Vimarsana News

Surprising Immune-Boosting Benefits of Tuberculosis Vaccine

A collaboration from scientists from Australia and the Netherlands has resulted in a fascinating new study showing immune-boosting ...

Beyond the Booster Shot - Vimarsana News

Beyond the Booster Shot

Could a “broad spectrum” booster increase our immunity to many pathogens simultaneously?

The Importance of Understanding the Nonspecific Effects of Vaccines - Vimarsana News

The Importance of Understanding the Nonspecific Effects of Vaccines

The world’s attention is presently focused on the mRNA vaccines, which may turn out to be the most revolutionary vaccines ever produced. However, very few doctors, and certainly not the public, have any awareness at all of the nonspecific effects of vaccines (NSEs). The specific effect of a vaccine is immunity to a target infection; the nonspecific effect refers to the off-target effects of all vaccines. These can be positive or negative. The beneficial effects are improved immunity to a variety of infections and all-round health, and the negative effects are the inverse—a predisposition ...

The mortality effects of disregarding the strategy to save doses of measles vaccine: a cluster-randomised trial in Guinea-Bissau - Guinea-Bissau - Vimarsana News

The mortality effects of disregarding the strategy to save doses of measles vaccine: a cluster-randomised trial in Guinea-Bissau - Guinea-Bissau

Abstract Introduction Measles vaccine (MV) may improve health beyond measles protection. To avoid wastage from multi-dose vials, children in Guinea-Bissau are only measles vaccinated when aged 9–11 months and when six or more children are present. We assessed health impacts of providing MV to all measles-unvaccinated children 9–35 months. Methods We cluster-randomised 182 village clusters under demographic surveillance in rural Guinea-Bissau to an ‘MV-for-all-policy’ arm where we offered MV regardless of age and number of children present at our bi-annual village visits, or a ‘Restr...